Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Firefly Neuroscience (AIFF) Cash from Investing Activities (2016 - 2025)

Firefly Neuroscience has reported Cash from Investing Activities over the past 15 years, most recently at -$23000.0 for Q4 2025.

  • Quarterly results put Cash from Investing Activities at -$23000.0 for Q4 2025, up 69.74% from a year ago — trailing twelve months through Dec 2025 was -$2.5 million (down 421.59% YoY), and the annual figure for FY2025 was -$2.5 million, down 421.59%.
  • Cash from Investing Activities for Q4 2025 was -$23000.0 at Firefly Neuroscience, up from -$86000.0 in the prior quarter.
  • Over the last five years, Cash from Investing Activities for AIFF hit a ceiling of $935974.0 in Q1 2023 and a floor of -$7.3 million in Q4 2021.
  • Median Cash from Investing Activities over the past 5 years was -$89000.0 (2024), compared with a mean of -$708899.3.
  • Biggest five-year swings in Cash from Investing Activities: tumbled 123351.67% in 2021 and later skyrocketed 8050.17% in 2023.
  • Firefly Neuroscience's Cash from Investing Activities stood at -$7.3 million in 2021, then skyrocketed by 95.86% to -$301842.0 in 2022, then decreased by 27.88% to -$386000.0 in 2023, then skyrocketed by 80.31% to -$76000.0 in 2024, then surged by 69.74% to -$23000.0 in 2025.
  • The last three reported values for Cash from Investing Activities were -$23000.0 (Q4 2025), -$86000.0 (Q3 2025), and -$2.4 million (Q2 2025) per Business Quant data.